Mulig terapeutisk intervention med hæmmere og fremmere af fosfolipase A 2 -subtyper

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Mulig terapeutisk intervention med hæmmere og fremmere af fosfolipase A 2 -subtyper. / Kolko, Miriam; Zhan, C.; Andreasen, J.R.; Prause, J.U.; Heegaard, S.

In: Ugeskrift for læger, Vol. 169, No. 2, 2007, p. 115-119.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Kolko, M, Zhan, C, Andreasen, JR, Prause, JU & Heegaard, S 2007, 'Mulig terapeutisk intervention med hæmmere og fremmere af fosfolipase A 2 -subtyper', Ugeskrift for læger, vol. 169, no. 2, pp. 115-119.

APA

Kolko, M., Zhan, C., Andreasen, J. R., Prause, J. U., & Heegaard, S. (2007). Mulig terapeutisk intervention med hæmmere og fremmere af fosfolipase A 2 -subtyper. Ugeskrift for læger, 169(2), 115-119.

Vancouver

Kolko M, Zhan C, Andreasen JR, Prause JU, Heegaard S. Mulig terapeutisk intervention med hæmmere og fremmere af fosfolipase A 2 -subtyper. Ugeskrift for læger. 2007;169(2):115-119.

Author

Kolko, Miriam ; Zhan, C. ; Andreasen, J.R. ; Prause, J.U. ; Heegaard, S. / Mulig terapeutisk intervention med hæmmere og fremmere af fosfolipase A 2 -subtyper. In: Ugeskrift for læger. 2007 ; Vol. 169, No. 2. pp. 115-119.

Bibtex

@article{342eb5b020ec11ddbc23000ea68e967b,
title = "Mulig terapeutisk intervention med h{\ae}mmere og fremmere af fosfolipase A 2 -subtyper",
abstract = "Summary Possible therapeutic intervention with inhibitors and promoters of phospholipase A2 subtypes Ugeskr L{\ae}ger 2007;169(2):115-9 Phospholipase A2 (PLA2 ) is a group of enzymes discovered more than a century ago in insect and snake poison. Not more than 20 years ago they were identified in vertebrates, and during the last five years, research has accelerated in relation to isolating and cloning several members of this super-family in humans. PLA2 inhibitors are in the process of being developed for pharmaceutical use. The purpose of this review is to outline the relevance and prospectives of PLA2 in a clinical perspective.",
author = "Miriam Kolko and C. Zhan and J.R. Andreasen and J.U. Prause and S. Heegaard",
year = "2007",
language = "Dansk",
volume = "169",
pages = "115--119",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "2",

}

RIS

TY - JOUR

T1 - Mulig terapeutisk intervention med hæmmere og fremmere af fosfolipase A 2 -subtyper

AU - Kolko, Miriam

AU - Zhan, C.

AU - Andreasen, J.R.

AU - Prause, J.U.

AU - Heegaard, S.

PY - 2007

Y1 - 2007

N2 - Summary Possible therapeutic intervention with inhibitors and promoters of phospholipase A2 subtypes Ugeskr Læger 2007;169(2):115-9 Phospholipase A2 (PLA2 ) is a group of enzymes discovered more than a century ago in insect and snake poison. Not more than 20 years ago they were identified in vertebrates, and during the last five years, research has accelerated in relation to isolating and cloning several members of this super-family in humans. PLA2 inhibitors are in the process of being developed for pharmaceutical use. The purpose of this review is to outline the relevance and prospectives of PLA2 in a clinical perspective.

AB - Summary Possible therapeutic intervention with inhibitors and promoters of phospholipase A2 subtypes Ugeskr Læger 2007;169(2):115-9 Phospholipase A2 (PLA2 ) is a group of enzymes discovered more than a century ago in insect and snake poison. Not more than 20 years ago they were identified in vertebrates, and during the last five years, research has accelerated in relation to isolating and cloning several members of this super-family in humans. PLA2 inhibitors are in the process of being developed for pharmaceutical use. The purpose of this review is to outline the relevance and prospectives of PLA2 in a clinical perspective.

M3 - Tidsskriftartikel

VL - 169

SP - 115

EP - 119

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 2

ER -

ID: 4038144